These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34929294)

  • 1. Unveiling the evolution routes of TEM-type extended-spectrum β-lactamases.
    Cheng Q; Cheung YC; Chan EWC; Wong KY; Chen S
    Int J Antimicrob Agents; 2022 Jan; 59(1):106498. PubMed ID: 34929294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
    Clasen J; Birkegård AC; Græsbøll K; Folkesson A
    J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
    Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
    J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of TEM-related extended-spectrum beta-lactamases in Korea.
    Pai H; Lee HJ; Choi EH; Kim J; Jacoby GA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3651-3. PubMed ID: 11709362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detrimental effect of the combination of R164S with G238S in TEM-1 beta-lactamase on the extended-spectrum activity conferred by each single mutation.
    Giakkoupi P; Tzelepi E; Tassios PT; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 2000 Jan; 45(1):101-4. PubMed ID: 10629019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases.
    Brown NG; Pennington JM; Huang W; Ayvaz T; Palzkill T
    J Mol Biol; 2010 Dec; 404(5):832-46. PubMed ID: 20955714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD; Shannon KP; French GL
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1881-7. PubMed ID: 10428907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
    Randegger CC; Hächler H
    J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
    Sideraki V; Huang W; Palzkill T; Gilbert HF
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
    Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and molecular characterization of TEM-116 extended-spectrum beta-lactamase produced by a Shigella flexneri clinical isolate from chickens.
    Hu GZ; Chen HY; Si HB; Deng LX; Wei ZY; Yuan L; Kuang XH
    FEMS Microbiol Lett; 2008 Feb; 279(2):162-6. PubMed ID: 18093137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Ripoll A; Baquero F; Novais A; Rodríguez-Domínguez MJ; Turrientes MC; Cantón R; Galán JC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4530-6. PubMed ID: 21788458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.
    Chang FY; Siu LK; Fung CP; Huang MH; Ho M
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2407-13. PubMed ID: 11502506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
    Robin F; Delmas J; Schweitzer C; Tournilhac O; Lesens O; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1304-9. PubMed ID: 17220412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases.
    Adamski CJ; Cardenas AM; Brown NG; Horton LB; Sankaran B; Prasad BV; Gilbert HF; Palzkill T
    Biochemistry; 2015 Jan; 54(2):447-57. PubMed ID: 25489790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
    Galán JC; Morosini MI; Baquero MR; Reig M; Baquero F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2551-7. PubMed ID: 12878518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.